Extrahepatic manifestations of HCV infection: A brief review and update

[1]  J. Piette,et al.  Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis. , 2006, Clinical biochemistry.

[2]  M. Ahern,et al.  Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab. , 2006, The Journal of rheumatology.

[3]  B. Julian,et al.  Brief Communication: Glomerulonephritis in Patients with Hepatitis C Cirrhosis Undergoing Liver Transplantation , 2006, Annals of Internal Medicine.

[4]  K. Petraki,et al.  Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis , 2006, Journal of viral hepatitis.

[5]  C. Giannini,et al.  Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment , 2006, Hepatology.

[6]  E. Vittinghoff,et al.  Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey. , 2006, Journal of the American Society of Nephrology : JASN.

[7]  M. Haberal,et al.  De novo glomerulonephritis in renal allografts with hepatitis C virus infection. , 2006, Transplantation proceedings.

[8]  Xiao-yuan Xu,et al.  [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus]. , 2006, Zhonghua yi xue za zhi.

[9]  L. Rostaing,et al.  Treatment of hepatitis C-virus-related glomerulonephritis. , 2006, Kidney international.

[10]  Y. Oshiro,et al.  Prevalence of hepatitis C virus infection in cases of B‐cell lymphoma in Japan , 2006, Histopathology.

[11]  R. Vieira,et al.  Linear lichen planus and hepatitis C. , 2006, Dermatology online journal.

[12]  A. Matsumori.  Role of hepatitis C virus in cardiomyopathies. , 2006, Ernst Schering Research Foundation workshop.

[13]  Y. Bacq,et al.  Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis. , 2006, Journal of hepatology.

[14]  F. Capani,et al.  Effects of Combined Antiviral Therapy on Asymptomatic Mixed Cryoglobulinemia in Naive Patients with Chronic Hepatitis C Virus Infection: A Preliminary Study , 2005, Digestive Diseases and Sciences.

[15]  D. Heisey,et al.  Positive Serum Cryoglobulin Is Associated with Worse Outcome after Liver Transplantation for Chronic Hepatitis C , 2005, Transplantation.

[16]  B. Smoller,et al.  Necrolytic acral erythema: a cutaneous sign of hepatitis C virus infection. , 2005, Journal of the American Academy of Dermatology.

[17]  M. Ramos-Casals,et al.  Extrahepatic manifestations in patients with chronic hepatitis C virus infection , 2005, Current opinion in rheumatology.

[18]  B. Fessler,et al.  Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. , 2005, The Journal of rheumatology.

[19]  U. Tirelli,et al.  Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. , 2005, Journal of hepatology.

[20]  D. Sansonno,et al.  Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. , 2005, The Lancet. Infectious diseases.

[21]  J. Piette,et al.  Vascular cell adhesion molecule-1 (VCAM-1) plays a central role in the pathogenesis of severe forms of vasculitis due to hepatitis C-associated mixed cryoglobulinemia. , 2005, Journal of hepatology.

[22]  J. Anaya,et al.  Sjögren Syndrome Associated With Hepatitis C Virus: A Multicenter Analysis of 137 Cases , 2005, Medicine.

[23]  J. Sánchez-Tapias,et al.  Sarcoidosis in Patients With Chronic Hepatitis C Virus Infection: Analysis of 68 Cases , 2005, Medicine.

[24]  J. Piette,et al.  PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. , 2005, Arthritis and rheumatism.

[25]  S. Morgello.  The nervous system and hepatitis C virus. , 2005, Seminars in liver disease.

[26]  A. Gabrielli,et al.  Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. , 2005, Archives of internal medicine.

[27]  B. Jaber,et al.  Ribavirin monotherapy for hepatitis C virus-associated membranous nephropathy. , 2005, Clinical nephrology.

[28]  M. Ramos-Casals,et al.  Extrahepatic manifestations in patients with chronic hepatitis C virus infection. , 2008 .

[29]  P. Harper,et al.  The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden. , 2005, Acta dermato-venereologica.

[30]  T. Niewold,et al.  Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C , 2005, Clinical Rheumatology.

[31]  M. Golightly,et al.  Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil , 2005, Rheumatology International.

[32]  G. Mazzucco,et al.  Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  H. Thomas,et al.  Central Nervous System Involvement in Hepatitis C Virus Infection , 2004, Metabolic Brain Disease.

[34]  C. la Vecchia,et al.  B‐cell non‐Hodgkin's lymphoma and hepatitis C virus infection: A systematic review , 2004, International journal of cancer.

[35]  E. Ferrannini,et al.  Thyroid disorders in chronic hepatitis C. , 2004, The American journal of medicine.

[36]  Claudio Michelassi,et al.  Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. , 2004, Seminars in arthritis and rheumatism.

[37]  G. Kaplanski,et al.  Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia. , 2004, Rheumatology.

[38]  F. D. De Rosa,et al.  Extrahepatic disease manifestations of HCV infection: some current issues. , 2004, Journal of hepatology.

[39]  T. Berg,et al.  Impact of in vivo complement activation and cryoglobulins on graft outcome of HCV‐infected renal allograft recipients , 2004, Clinical transplantation.

[40]  A. Sherker,et al.  Case Report: Fatal Exacerbation of Hepatitis C-Related Cryoglobulinemia with Interferon-alpha Therapy , 1999, Digestive Diseases and Sciences.

[41]  M. Sobh,et al.  The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[42]  J. Jimenez-Heffernan,et al.  Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. , 2004, The Journal of infectious diseases.

[43]  J. Kench,et al.  Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression , 2003 .

[44]  C. Scagnolari,et al.  Occult hepatitis C virus infection in type II mixed cryoglobulinaemia , 2003, Journal of viral hepatitis.

[45]  J. Gisbert,et al.  Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. , 2003, Journal of hepatology.

[46]  S. Fargion,et al.  Prevalence of hepatitis C virus infection in porphyria cutanea tarda. , 2003, Journal of hepatology.

[47]  R. Wolfe,et al.  Chronic renal failure after transplantation of a nonrenal organ. , 2003, The New England journal of medicine.

[48]  A. Bruchfeld,et al.  Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[49]  J. Pankow,et al.  Hepatitis C virus infection and incident type 2 diabetes , 2003, Hepatology.

[50]  G. Mazzucco,et al.  Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy. , 2003, Kidney international.

[51]  Felicia A Tucci,et al.  Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. , 2003, Blood.

[52]  R. Torella,et al.  Prevalence and Incidence of Cryoglobulins in Hepatitis C Virus–Related Chronic Hepatitis Patients: A Prospective Study , 2003, American Journal of Gastroenterology.

[53]  D. Morganti,et al.  Celiac sprue: another autoimmune syndrome associated with hepatitis C? , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[54]  H. El‐Serag,et al.  Extrahepatic manifestations of hepatitis C among United States male veterans , 2002, Hepatology.

[55]  W. Irving,et al.  Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[56]  B. Zimmerman,et al.  Hepatitis C, cryoglobulinemia, and cirrhosis: A meta‐analysis , 2002, Hepatology.

[57]  L. Guillevin,et al.  Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. , 2002, Rheumatology.

[58]  C. Ferri,et al.  Erectile dysfunction and hepatitis C virus infection. , 2002, JAMA.

[59]  X. Mariette,et al.  Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. , 2002, The New England journal of medicine.

[60]  Y. Nojima,et al.  Steroid‐refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection , 2002, European journal of haematology.

[61]  R. Chamuleau,et al.  Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin , 2001, Journal of Gastroenterology.

[62]  B. Vergès,et al.  Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. , 2001, Journal of hepatology.

[63]  R. Willson.  The benefit of long-term interferon alfa therapy for symptomatic mixed cryoglobulinemia (cutaneous vasculitis/membranoproliferative glomerulonephritis) associated with chronic hepatitis C infection. , 2001, Journal of clinical gastroenterology.

[64]  G. Wood,et al.  Necrolytic acral erythema associated with hepatitis C: effective treatment with interferon alfa and zinc. , 2000, Archives of dermatology.

[65]  J. Stapleton,et al.  Hepatitis C virus (HCV) infection and cryoglobulinemia: Analysis of whole blood and plasma HCV‐RNA concentrations and correlation with liver histology , 2000, Hepatology.

[66]  Cobelli,et al.  Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon‐α , 2000, European journal of clinical investigation.

[67]  J. Piette,et al.  Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. , 2000, Medicine.

[68]  D. Sansonno,et al.  The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. , 2000, Seminars in liver disease.

[69]  M. Weitzman,et al.  Refractory scleritis in a patient with cryoglobulinemia and hepatitis C. , 1999, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[70]  J. Vílchez,et al.  Neurologic complications associated with hepatitis C virus infection , 1999, Neurology.

[71]  G. Alexander,et al.  Association of diabetes mellitus and chronic hepatitis C virus infection , 1999, Hepatology.

[72]  M. Biasin,et al.  Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis. , 1998, Journal of hepatology.

[73]  M. Kondo,et al.  Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C. , 1997, Hepato-gastroenterology.

[74]  H. Bolay,et al.  PCR detected hepatitis C virus genome in the brain of a case with progressive encephalomyelitis with rigidity , 1996, Clinical Neurology and Neurosurgery.

[75]  M. Marazuela,et al.  Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon‐α therapy , 1996, Clinical endocrinology.

[76]  H. Tsubouchi,et al.  Retinal complications during interferon therapy for chronic hepatitis C. , 1996, The American journal of gastroenterology.

[77]  J. Pouget,et al.  Myasthenia gravis and hepatitis C virus infection , 1995, Journal of viral hepatitis.

[78]  J. Pawlotsky,et al.  Hepatitis C virus infection and autoimmune thrombocytopenic purpura. , 1995, Journal of hepatology.

[79]  D. Schuppan,et al.  Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in germany , 1995, Hepatology.

[80]  J. Auran,et al.  Interferon treatment of Mooren's ulcers associated with hepatitis C. , 1995, American journal of ophthalmology.

[81]  E. Tanzi,et al.  Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. , 1994, The New England journal of medicine.

[82]  U. Protzer,et al.  Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C. , 1993, Gastroenterology.

[83]  P. Couzigou,et al.  Lichen planus and virus C hepatitis: disappearance of the lichen under interferon alfa therapy. , 1992, Dermatology.

[84]  L. Perrin,et al.  Hepatitis C virus in patients with cryoglobulinemia type II. , 1990, The Journal of infectious diseases.

[85]  J. Clauvel,et al.  Biologic and clinical significance of cryoglobulins. A report of 86 cases. , 1974, The American journal of medicine.